2020 Publication Archive

An Interprofessional Workshop to Enhance De-prescribing Practices Among Health Care Providers

Zimmerman KM, Linsky AM, Donohoe KL, Hobgood SE, Sargent L, Salgado TM.

J Contin Educ Health Prof. 2020;40(1):49-57. doi: 10.1097/CEH.0000000000000280.

Pharmacist-administered long-acting injectable PCSK9 service: A solution to improve patient access and adherence

Dixon DL, Saseen JJ.

J Am Pharm Assoc (2003). 2021;61(3):e83-e85. doi: 10.1016/j.japh.2020.12.009.

A key performance indicators redefinition initiative at a school of pharmacy using a modified Delphi consensus technique

Salgado TM, Reynolds TN, Frankart LM, Holdford DA, DiPiro JT, VCU School of Pharmacy KPIs Redefinition Taskforce.

Pharm Pract (Granada). 2020;18(4):2120. doi: 10.18549/PharmPract.2020.4.2120. 

Point-Of-Care Testing in Pharmacies – An evaluation of the service from the lens of resource-based theory of competitive advantage

Pontinha VMWagner TD, Holdford DA.

J Am Pharm Assoc (2003). 2021;61(2):e45-e54. doi: 10.1016/j.japh.2020.11.005. 

Sex and Age Differences in Ambulatory Blood Pressure Monitoring Tolerability

Khaddage SJ, Patterson JA, Sargent LJ, Price ET, Dixon DL.

Am J Hypertens. 2021;34(4):335-338. doi: 10.1093/ajh/hpaa182. 

CMS Mega-Rule Update and the Status of Pharmacy-Related Deficiencies in Nursing Homes

Wesson KW, Donohoe KL, Patterson JA.

J Appl Gerontol. 2021;40(11):1617-1627. doi: 10.1177/0733464820967589. 

Primary healthcare policy and vision for community pharmacy and pharmacists in the United States

Salgado TM, Rosenthal MM, Coe AB, Kaefer TN, Dixon DL, Farris KB.

Pharm Pract (Granada). 2020;18(3):2160. doi: 10.18549/PharmPract.2020.3.2160. 

Screening, identification, and management of prediabetes to reduce cardiovascular risk: A missed opportunity?

Dixon DL, Carbone S.

Diabetes Metab Res Rev. 2020;36(6):e3316. doi: 10.1002/dmrr.3316. 

Medication Adherence Trajectories: A Systematic Literature Review

Alhazami M, Pontinha VM, Patterson JA, Holdford DA.

J Manag Care Spec Pharm. 2020;26(9):1138-1152. doi: 10.18553/jmcp.2020.26.9.1138. 

Best practices for safe use of SGLT-2 inhibitors developed from an expert panel Delphi consensus process.

Pamulapati LG, Rochester-Eyeguokan CD, Pincus KJ.

Am J Health Syst Pharm. 2020;77(21):1727-1738. doi: 10.1093/ajhp/zxaa243. 

Development and feasibility of a community pharmacy–driven 24-hour ambulatory blood pressure monitoring service

Dixon DL, Patterson JA, Gatewood SS, Kaefer T, Jadallah J, Curtis M, Hawkey L, Grigsby J, Salgado TM, Holdford DA.

J Am Pharm Assoc (2003). 2020;60(6):e332-e340. doi: 10.1016/j.japh.2020.06.007. 

Challenges in pharmacotherapy for older adults: a framework for pharmacogenomics implementation.

Roman YM, Dixon DL, Salgado TM, Price ET, Zimmerman KM, Sargent L, Slattum PW.

Pharmacogenomics. 2020;21(9):627-635. doi: 10.2217/pgs-2019-0198. 

Role delineation for pharmacotherapy specialists: Re-evaluating the clinical relevance of a patient-centered credential

Muckle T, Blair M, Badowski ME, Yam F, Johnson SG.

J Am Coll Clin Pharm. 20209; 1–9. doi: https://doi.org/10.1002/jac5.1263.

Effect of Pharmacist Interventions on Reducing Low-Density Lipoprotein Cholesterol (LDL-C) Levels: A Systematic Review and Meta-Analysis

Dixon DL, Khaddage S, Bhagat S, Koenig RA, Salgado TM, Baker WL.

J Clin Lipidol. 2020;14(3):282-292.e4. doi: 10.1016/j.jacl.2020.04.004. 

Pharmacist's role in hypertension management: a review of key randomized controlled trials

Wagner TD, Jones MC, Salgado TMDixon DL.

J Hum Hypertens. 2020;34(7):487-494. doi: 10.1038/s41371-020-0331-7. 

Characterization of pharmacy practice research centers across the United States

Salgado TM, Patterson JA, Bajaj SK, Lajthia E, Zimmerman KM, Fernandez-Llimos F, Dixon DL.

Res Social Adm Pharm. 2020;16(2):230-237. doi: 10.1016/j.sapharm.2019.05.009. 

How many manuscripts should I peer review per year?

Fernandez-Llimos F, Salgado TM, Tonin FS.

Pharm Pract (Granada). 2020;18(1):1804. doi: 10.18549/PharmPract.2020.1.1804.

Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide 1 Receptor Agonist

Bucheit JD, Pamulapati LG, Carter N, Malloy K, Dixon DL, Sisson EM.

Diabetes Technol Ther. 2020;22(1):10-18. doi: 10.1089/dia.2019.0185.